European Working Group on Sarcopenia in Older People guideline 에 근거한 혈중 인슐린양 성장인자-1과 근육량, 근력, 신체수행능력과의 상관관계

DC Field Value Language
dc.contributor.advisor김광민-
dc.contributor.authorKim, Se Il-
dc.date.accessioned2019-10-21T07:22:43Z-
dc.date.available2019-10-21T07:22:43Z-
dc.date.issued2014-02-
dc.identifier.other16237-
dc.identifier.urihttps://dspace.ajou.ac.kr/handle/2018.oak/18359-
dc.description학위논문(석사)--아주대학교 일반대학원 :의학과,2014. 2-
dc.description.tableofcontentsTABLE OF CONTENTS ABSTRACT .......................................................................................................................... ⅰ TABLE OF CONTENTS ........................................................................................................ii LIST OF FIGURES ................................................................................................................iii LIST OF TABLES ................................................................................................................. iv I. INTRODUCTION ................................................................................................................1 II. MATERIALS AND METHODS .........................................................................................3 A. Study Subjects ...................................................................................................................3 B. Body composition and blood test ……..............................................................................3 C. Muscle mass, muscle strength, physical performance ...………………………………....3 D. Definition of sarcopenia ………………………………………………………................4 E. Statistical analysis ………………………………………………………………………. 5 III. RESULTS............................................................................................................................6 A. Baseline characteristics ………………………………………………………………….6 B. IGF-1 level and muscle mass, muscle strength and physical performance………………7 C. Sarcopenia………………………………………………………………………………..8 D. Sarcopenia and IGF-1 level…………………………………………………………… .11 IV. DISCUSSION....................................................................................................................14 V. CONCLUSION...................................................................................................................17 REFERENCES .......................................................................................................................18 국문요약 ...............................................................................................................................21 Fig. 1. Serum IGF-1 level in different age groups .................................................................. 7 Fig. 2. Prevalence of sarcopenia .............................................................................................. 9 Table 1. General characteristics of participants ....................................................................... 6 Table 2. Correlation serum IGF-1 and muscle mass, muscle strength, physical performance and age ..................................................................................................................... 8 Table 3. Odds ratio of sarcopenia components according to IGF-1 quartile ......................... 12 Table 4. Odds ratio of sarcopenia prevalence according to IGF-1 quartile ........................... 13-
dc.language.isoeng-
dc.publisherThe Graduate School, Ajou University-
dc.rights아주대학교 논문은 저작권에 의해 보호받습니다.-
dc.titleEuropean Working Group on Sarcopenia in Older People guideline 에 근거한 혈중 인슐린양 성장인자-1과 근육량, 근력, 신체수행능력과의 상관관계-
dc.title.alternativeKIMSEIL-
dc.typeThesis-
dc.contributor.affiliation아주대학교 일반대학원-
dc.contributor.alternativeNameKIMSEIL-
dc.contributor.department일반대학원 의학과-
dc.date.awarded2014. 2-
dc.description.degreeMaster-
dc.identifier.localId608214-
dc.identifier.urlhttp://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000016237-
dc.subject.keywordInsulin like growth factor-1 (IGF-1)-
dc.subject.keywordMuscle mass-
dc.subject.keywordMuscle strength-
dc.subject.keywordPhysical performance-
dc.subject.keywordSarcopenia.-
dc.description.alternativeAbstractBackground : Aging is associated with various changes in body composition, such as a decrease in muscle mass, bone mineral density, and an increase in body fat. We assumed that these changes were accompanied by decrease of IGF-1 level. We aimed to define relationship between IGF-1 level and muscle mass, muscle strength and physical function of the middle aged people and the elderly. Method : In the cross-sectional study, subjects were included who had medical examination in the Ajou University health promotion center. Serum IGF-1 level was measured, and muscle mass was calculated by dual-energy X-ray absorptiometry (DXA). Muscle strength was measured by hand grip strength test and physical performance was tested by 2-m walking test. Results : Mean IGF-1 level was 191.1 ± 50.8 ng /ml in men and was 168.3 ± 49.0 ng /ml in women respectively. Serum IGF-1 level was associated with muscle mass in both genders. Muscle strength and physical performance were positively associated with IGF-1 in women. We also investigated prevalence of sarcopenia based on the definition of European Working Group on Sarcopenia in Older People (EGWSOP) guideline. The prevalence of sarcopenia was associated with low serum IGF-1 level in women. Conclusion : We observed IGF-I was associated with muscle mass in both genders and it was related with muscle strength and physical performance in women. In addition, prevalecnce of sarcopenia was associated with low serum IGF-1 level.-
Appears in Collections:
Graduate School of Ajou University > Department of Medicine > 3. Theses(Master)
Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse